NCT00834652View on ClinicalTrials.gov

Adding an Insulin-Sensitizing Medication to Depression Treatment for People Who Are Depressed and Overweight

PHASE4CompletedINTERVENTIONAL

Enrollment

206

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions

Depression

Interventions

DRUG

Sertraline

50 mg once a day, which may be increased to 200 mg once a day

DRUG

Metformin

Starting dose of 500 mg daily and increasing by 500 mg every 2 weeks to a total of 2,000 mg daily

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Washington University School of Medicine

OTHER

NCT00834652 - Adding an Insulin-Sensitizing Medication to Depression Treatment for People Who Are Depressed and Overweight | Biotech Hunter | Biotech Hunter